Podcast Episodes

Back to Search
EMCrit 379 - Procedural Sedation Part IV - the Critically Ill Patient and MidaKet
EMCrit 379 - Procedural Sedation Part IV - the Critically Ill Patient and MidaKet

1 year, 6 months ago

Short Long
View Episode
EMCrit Wee - Don't be so Quick to Blow-Off New-Onset Atrial Fibrillation (A-Fib)
EMCrit Wee - Don't be so Quick to Blow-Off New-Onset Atrial Fibrillation (A-Fib)

1 year, 6 months ago

Short Long
View Episode
EMCrit 378 - So NSTI - Necrotizing Fasciitis & Life Threatening Soft Tissue Infections
EMCrit 378 - So NSTI - Necrotizing Fasciitis & Life Threatening Soft Tissue Infections

1 year, 6 months ago

Short Long
View Episode
EMCrit Wee - Adaptive Support Ventilation (ASV)
EMCrit Wee - Adaptive Support Ventilation (ASV)

1 year, 6 months ago

Short Long
View Episode
EMCrit Wee - Additional Thoughts on the PREOXI Trial
EMCrit Wee - Additional Thoughts on the PREOXI Trial

1 year, 6 months ago

Short Long
View Episode
EMCrit 377 - Break News - The PREOXI Trial changes everything about Preoxygenation for Intubations in the Critically Ill
EMCrit 377 - Break News - The PREOXI Trial changes everything about Preoxygenation for Intubations in the Critically Ill

1 year, 7 months ago

Short Long
View Episode
EMCrit Wee - Controlled Automated Reperfusion of the Whole Body (CARL) ECPR / ECLS Yields Amazing Results
EMCrit Wee - Controlled Automated Reperfusion of the Whole Body (CARL) ECPR / ECLS Yields Amazing Results

1 year, 7 months ago

Short Long
View Episode
EMCrit 376 - Do We Need ETCO2 (Capnography) for Procedural Sedation in the ED?
EMCrit 376 - Do We Need ETCO2 (Capnography) for Procedural Sedation in the ED?

1 year, 7 months ago

Short Long
View Episode
CV-EMCrit - Post-CABG Care
CV-EMCrit - Post-CABG Care

1 year, 7 months ago

Short Long
View Episode
EMCrit 375 - Vasopressors for Early Hemorrhage?
EMCrit 375 - Vasopressors for Early Hemorrhage?

1 year, 7 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us